All Relations between Autism Spectrum Disorder and cannabis

Reference Sentence Publish Date Extraction Date Species
Noa Raz, Iso Heller, Titti Lombardi, Giorgio Marino, Elyad M Davidson, Aharon M Eya. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Frontiers in pharmacology vol 13 issue 2022 36386202 cannabidiol (cbd) rich products are successfully used in some countries for treating symptoms associated with autism spectrum disorder (asd). 2022-11-17 2022-11-21 Not clear
Lucy Ma, Sofia Platnick, Howard Platnic. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study. Cureus vol 14 issue 8 2022 36176817 cannabidiol in treatment of autism spectrum disorder: a case study. 2022-09-30 2022-10-10 Not clear
Lucy Ma, Sofia Platnick, Howard Platnic. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study. Cureus vol 14 issue 8 2022 36176817 this case study aims to demonstrate the use of cannabidiol (cbd) with low-dose tetrahydrocannabinol (thc) in managing symptoms associated with autism spectrum disorder (asd)\xc2\xa0to increase the overall quality of life for these individuals and their families. 2022-09-30 2022-10-10 Not clear
Jo\\xc3\\xa3o F C Pedrazzi, Frederico R Ferreira, Danyelle Silva-Amaral, Daniel A Lima, Jaime E C Hallak, Ant\\xc3\\xb4nio W Zuardi, Elaine A Del-Bel, Francisco S Guimar\\xc3\\xa3es, Karla C M Costa, Alline C Campos, Ana C S Crippa, Jos\\xc3\\xa9 A S Cripp. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology vol issue 2022 35904579 cannabidiol for the treatment of autism spectrum disorder: hope or hype? 2022-07-29 2022-08-08 Not clear
Rubens Pitliuk, Christina Morotomi Funatsu Coelho, Tatyanny Paula Pinto da Costa Santos Fucc. Unexpected improvement of hyperhidrosis with cannabidiol. Einstein (Sao Paulo, Brazil) vol 20 issue 2022 35170710 the first patient received cannabidiol specific for public presentations at work, and the second patient had a diagnosis of autism spectrum disorder. 2022-02-16 2022-02-17 Not clear
Jos\\xc3\\xa9 Carlos Pastrana-Trejo, F\\xc3\\xa1tima Duarte-Ak\\xc3\\xa9, Rosa Us-Camas, Clelia De-la-Pe\\xc3\\xb1a, Linda Parker, Roger G Pertwee, Eric Murillo-Rodr\\xc3\\xadgue. Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study. Central nervous system agents in medicinal chemistry vol 21 issue 2 2021 32972354 cannabidiol (cbd), a non-psychotropic constituent of cannabis sativa, has shown therapeutic promises by modulating several pathological conditions, including pain, epilepsy autism, among others. 2021-10-25 2022-01-13 Not clear
C\\xc3\\xa1ssio Morais Loss, Lucas Teodoro, Gabriela Don\\xc3\\xa1 Rodrigues, Lucas Roberto Moreira, Fernanda Fiel Peres, Antonio Waldo Zuardi, Jos\\xc3\\xa9 Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Vanessa Costhek Ab\\xc3\\xadli. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders? Frontiers in pharmacology vol 11 issue 2021 33613289 is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? 2021-02-23 2022-01-13 Not clear
Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren, Matitiahu Berkovitc. Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities. Frontiers in pharmacology vol 9 issue 2020 30687090 oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. 2020-10-01 2022-01-13 Not clear
Carlos A Salgado, Daniel Castellano. Autism Spectrum Disorder and Cannabidiol: Have We Seen This Movie Before? Global pediatric health vol 5 issue 2020 30547057 autism spectrum disorder and cannabidiol: have we seen this movie before? 2020-09-29 2022-01-13 Not clear
Adi Aran, Dalit Cayam-Ran. Medical Cannabis in Children. Rambam Maimonides medical journal vol 11 issue 1 2020 32017680 while robust evidence currently exists only for pure cannabidiol (cbd) to treat specific types of refractory epilepsy, in most cases, artisanal strains of cbd-rich medical cannabis are being used to treat children with various types of refractory epilepsy or irritability associated with autism spectrum disorder (asd). 2020-09-28 2022-01-13 Not clear
Charlotte M Pretzsch, Bogdan Voinescu, Maria A Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Steven Williams, Declan Gm Murphy, Eileen Daly, Gr\\xc3\\xa1inne M McAlona. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). Journal of psychopharmacology (Oxford, England) vol 33 issue 9 2020 31237191 the effect of cannabidiol (cbd) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (asd). 2020-08-12 2022-01-13 Not clear
Charlotte M Pretzsch, Bogdan Voinescu, Maria A Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Steven Williams, Declan Gm Murphy, Eileen Daly, Gr\\xc3\\xa1inne M McAlona. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). Journal of psychopharmacology (Oxford, England) vol 33 issue 9 2020 31237191 the potential benefits of cannabis and its major non-intoxicating component cannabidiol (cbd) are attracting attention, including as a potential treatment in neurodevelopmental disorders such as autism spectrum disorder (asd). 2020-08-12 2022-01-13 Not clear
Charlotte Marie Pretzsch, Jan Freyberg, Bogdan Voinescu, David Lythgoe, Jamie Horder, Maria Andreina Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Richard A E Edden, Steven Williams, Declan G M Murphy, Eileen Daly, Gr\\xc3\\xa1inne M McAlona. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol 44 issue 8 2020 30758329 effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. 2020-03-31 2022-01-13 Not clear
Charlotte Marie Pretzsch, Jan Freyberg, Bogdan Voinescu, David Lythgoe, Jamie Horder, Maria Andreina Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Richard A E Edden, Steven Williams, Declan G M Murphy, Eileen Daly, Gr\\xc3\\xa1inne M McAlona. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol 44 issue 8 2020 30758329 there is increasing interest in the use of cannabis and its major non-intoxicating component cannabidiol (cbd) as a treatment for mental health and neurodevelopmental disorders, such as autism spectrum disorder (asd). 2020-03-31 2022-01-13 Not clear
Shani Poleg, Pavel Golubchik, Daniel Offen, Abraham Weizma. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in neuro-psychopharmacology & biological psychiatry vol 89 issue 2019 30171992 cannabidiol as a suggested candidate for treatment of autism spectrum disorder. 2019-03-25 2022-01-13 Not clear
Theodora Nelson, Yi Hui Liu, Kara S Bagot, Martin T Stei. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions. Journal of developmental and behavioral pediatrics : JDBP vol 38 issue 6 2018 28622159 alex states that he uses marijuana to relieve his anxiety and does not understand why this is problematic as marijuana is now legal in his state.kevin is a 24-year-old adult man with diagnoses of autism spectrum disorder, mild intellectual disability, and schizoaffective disorder. 2018-04-05 2022-01-13 Not clear
Theodora Nelson, Yi Hui Liu, Kara S Bagot, Martin T Stei. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions. Journal of developmental and behavioral pediatrics : JDBP vol 38 issue 6 2018 28622159 his father hopes that the marijuana will allow kevin's other medications to be decreased or discontinued.linda is an 11-year-old girl with high-functioning autism spectrum disorder, anxiety, and adhd-inattentive subtype. 2018-04-05 2022-01-13 Not clear
K Blum, E R Braverman, J M Holder, J F Lubar, V J Monastra, D Miller, J O Lubar, T J Chen, D E Coming. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of psychoactive drugs vol 32 Suppl issue 2001 11280926 therefore lack of d2 receptors causes individuals to have a high risk for multiple addictive, impulsive and compulsive behavioral propensities, such as severe alcoholism, cocaine, heroin, marijuana and nicotine use, glucose bingeing, pathological gambling, sex addiction, adhd, tourette's syndrome, autism, chronic violence, posttraumatic stress disorder, schizoid/avoidant cluster, conduct disorder and antisocial behavior. 2001-04-26 2022-01-11 Not clear
Page: 
1